A 2-year placebo-controlled study of orlistat in the treatment of obesity.

被引：0
|
作者：
Lucas, C
机构：
来源：
DIABETES | 1997年 / 46卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：339 / 339
页数：1
相关论文
共 50 条
  • [1] Olanzapine for treatment of the schizophrenia prodrome: 2-year results of a randomized placebo-controlled study
    McGlashan, TH
    Zipursky, RB
    Perkins, DO
    Addington, J
    SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 164 - 164
  • [2] Olanzapine for treatment of the schizophrenia prodrome: 2-year results of a randomized placebo-controlled study
    McGlashan, TH
    Zipursky, RB
    Perkins, DO
    Addington, J
    Woods, SW
    Miller, TJ
    Lindborg, SR
    Trzaskoma, Q
    Hawkins, K
    Breier, A
    BIOLOGICAL PSYCHIATRY, 2004, 55 : 226S - 226S
  • [3] One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
    N Finer
    WPT James
    PG Kopelman
    MEJ Lean
    G Williams
    International Journal of Obesity, 2000, 24 : 306 - 313
  • [4] One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor
    Finer, N
    James, WPT
    Kopelman, PG
    Lean, MEJ
    Williams, G
    INTERNATIONAL JOURNAL OF OBESITY, 2000, 24 (03) : 306 - 313
  • [5] Orlistat in the treatment of chylomicronemia:: Results of a randomized, placebo-controlled, crossover study
    Aguilar-Salinas, CA
    Novoa, J
    Ramirez, E
    Gómez-Pérez, FJ
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2003, 23 (05) : A22 - A22
  • [6] PLACEBO-CONTROLLED STUDY OF TERAZOSIN IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA WITH 2-YEAR FOLLOW-UP
    FABRICIUS, PG
    MACHANNAFORD, J
    BRITISH JOURNAL OF UROLOGY, 1992, 70 : 10 - 16
  • [7] A 2-year randomised placebo-controlled trial of doxycycline for lymphangioleiomyomatosis
    Chang, William Y. C.
    Cane, Jennifer L.
    Kumaran, Maruti
    Lewis, Sarah
    Tattersfield, Anne E.
    Johnson, Simon R.
    EUROPEAN RESPIRATORY JOURNAL, 2014, 43 (04) : 1114 - 1123
  • [8] Effects of galantamine in a 2-year, randomized, placebo-controlled study in Alzheimer's disease
    Hager, Klaus
    Baseman, Alan S.
    Nye, Jeffrey S.
    Brashear, H. Robert
    Han, John
    Sano, Mary
    Davis, Bonnie
    Richards, Henry M.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 391 - 401
  • [9] A 2-year, randomized, comparative, placebo-controlled study on the effects of raloxifene on lipoprotein(a) and homocysteine
    Smolders, RGV
    Vogelvang, TE
    Mijatovic, V
    van Baal, WM
    Neele, SJM
    Netelenbos, JC
    Kenemans, P
    van der Mooren, MJ
    MATURITAS, 2002, 41 (02) : 105 - 114
  • [10] A 2 year, US, randomized, controlled study of orlistat, a gastrointestinal lipase inhibitor, for obesity treatment
    Davidson, M
    CIRCULATION, 1997, 96 (08) : 4119 - 4119
12345